2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-02-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13108471 2024-02-01 2025-01-31 13108471 2025-01-31 13108471 2024-01-31 13108471 2023-02-01 2024-01-31 13108471 2024-01-31 13108471 2023-01-31 13108471 bus:Director1 2024-02-01 2025-01-31 13108471 core:WithinOneYear 2025-01-31 13108471 core:WithinOneYear 2024-01-31 13108471 bus:Micro-entities 2024-02-01 2025-01-31 13108471 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 13108471 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 13108471 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 13108471 bus:FullAccounts 2024-02-01 2025-01-31
COMPANY REGISTRATION NUMBER: 13108471
Infection Specialist Services Limited
Filleted Unaudited Financial Statements
31 January 2025
Infection Specialist Services Limited
Statement of Financial Position
31 January 2025
2025
2024
£
£
Fixed assets
5,523
2,964
-------
-------
Current assets
188,313
145,482
Creditors: amounts falling due within one year
14,439
16,239
---------
---------
Net current assets
173,874
129,243
---------
---------
Total assets less current liabilities
179,397
132,207
Accruals and deferred income
1,298
1,183
---------
---------
178,099
131,024
---------
---------
Capital and reserves
178,099
131,024
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
2. Director's advances, credits and guarantees
The director’s loan account is not disclosed as permitted under FRS 105.
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 18 August 2025 , and are signed on behalf of the board by:
Dr Godbole
Director
Company registration number: 13108471
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 27, Beechcroft Road, Bushey, Herts, WD23 2JU, England.